Login to Your Account

Pharma: Other News To Note

Monday, June 11, 2012

• Mylan Pharmaceuticals Inc., of Pittsburgh, settled a dispute with Teva Pharmaceuticals USA Inc., part of Teva Pharmaceutical Industries Ltd., of Jerusalem, over litigation brought by Mylan against the FDA related to Mylan's abbreviated new drug application for Modafinil tablets, 100 mg and 200 mg.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription